Daines Silent as Trump Administration Ousts Official Who Pushed Back on Treatment He’s Invested In
FOR IMMEDIATE RELEASE
Thursday, April 23, 2020
CONTACT
press@montanademocrats.org
Daines Silent as Trump Administration Ousts Official Who Pushed Back on Treatment He’s Invested In
Helena, MT – The former head of the office involved with finding a COVID-19 vaccine says he was forced out for pushing back on an unproven treatment being touted by Senator Steve Daines. Daines recently highlighted the potential of the drug hydroxychloroquine in an interview, and new reporting reveals that Daines has investments in companies producing the drug.
Yesterday, Dr. Rick Bright said he was removed as director of the Biomedical Advanced Research and Development Authority for pushing back on the broad use of hydroxychloroquine. Daines has remained silent on Dr. Rick Bright being ousted, and has not commented on whether his financial stake in companies producing hydroxychloroquine has impacted his public stance on the drug’s potential — despite serious questions as to its safety and efficacy.
“The development of COVID-19 treatment must be determined by scientific inquiry, not Steve Daines’ investment portfolio,” said MDP Executive Director Sandi Luckey
###